JPMorgan Chase & Co’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15
| Closed | -$34 | – | 6745 |
|
|
2025
Q1 | $34 | Sell |
15
-2
| -12% | -$5 | ﹤0.01% | 6166 |
|
|
2024
Q4 | $65 | Hold |
17
| – | – | ﹤0.01% | 6025 |
|
|
2024
Q3 | $51 | Buy |
17
+15
| +750% | +$45 | ﹤0.01% | 6049 |
|
|
2024
Q2 | $6 | Buy |
+2
| New | +$6 | ﹤0.01% | 6214 |
|
|
2023
Q4 | – | Sell |
-3,358
| Closed | -$9.2K | – | 6770 |
|
|
2023
Q3 | $9.2K | Buy |
+3,358
| New | +$9.2K | ﹤0.01% | 5337 |
|
|
2023
Q2 | – | Sell |
-208
| Closed | -$1K | – | 6325 |
|
|
2023
Q1 | $1K | Buy |
+208
| New | +$1K | ﹤0.01% | 5692 |
|